Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints Dr Yong-Jun Liu as head of research

He brings experience from MedImmune and the Baylor Research Institute

Sanofi Dr Yong-Jun LiuSanofi has appointed Dr Yong-Jun Liu as head of research, global research and development, which he will commence from 1 April.

In his new role, Dr Liu will be responsible for all of the Paris-based pharmaceutical company's research and will be tasked with delivering innovative and high-value medicines.

Reporting to Dr Elias Zerhouni, president of global research and development at Sanofi, Dr Liu will work with the senior leadership team to build up the firm's research and development division to perform on both internal and external platforms.

Dr Zerhouni said: “Yong-Jun will play a pivotal role in shaping a visionary R&D strategy for Sanofi and rejuvenating the company's early-stage pipeline.

“His world-class experience in immunology, oncology and translational medicine will be vital assets as Sanofi sets its sights on scientific excellence and innovation across its therapeutic areas.”

Dr Liu has over 25 years of experience in the pharmaceutical industry and at leading medical research centres, including Schering-Plough and the University of Texas' Cancer Immunology Research Institute.

He joined the Baylor Research Institute as vice president and chief scientific officer as well as director of its Institute for Immunology Research in 2011. In January 2014, Dr Liu was appointed head of research at MedImmune, his most recent position.

Dr Olivier Brandicourt, Sanofi's chief executive officer, said: “I have great confidence that Yong-Jun will position Sanofi on the leading edge of scientific breakthroughs and drug discovery in the years ahead.”

30th March 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics